Literature DB >> 12165739

Patient, community and clinician perceptions of the quality of life associated with diabetes mellitus.

Jennifer Landy1, Joshua Stein, Melissa M Brown, Gary C Brown, Sanjay Sharma.   

Abstract

BACKGROUND: A study was undertaken to assess the quality of life of patients with type 1 and type 2 diabetes mellitus and to ascertain whether clinicians and non-diabetic respondents from the general public have similar views of the impact of diabetes upon health-related quality of life. MATERIAL/
METHODS: Time tradeoff utility values were generated from a standardized time-tradeoff questionnaire. Three hundred and fifty-two individuals with type 1 or type 2 diabetes mellitus, 157 non-diabetic participants from the general public (community), and 61 health care clinicians participated in the study.
RESULTS: The mean utility score for diabetic patients was 0.889 and the median utility score was 1.000. The mean utility score for clinicians was 0.861, with a median value of 0.894, while the respective mean and median scores for the general public were 0.919 and 0.953. There was a significant difference between the distribution of the means of scores of clinicians and patients as well as between clinicians and the general public. There was no significant difference between the utility scores of patients and the general public. Within the group of diabetic patients, there was no significant difference in utility scores between type 1 and type 2 diabetics.
CONCLUSIONS: Clinicians tended to overemphasize the impact that diabetes mellitus has on health related quality of life, while the non-diabetic publics' utility values are more closely correlated with those of diabetics themselves. We conclude that there is a significant difference in how clinicians, diabetics and the general public perceive the effect diabetes has upon quality of life.

Entities:  

Mesh:

Year:  2002        PMID: 12165739

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  7 in total

Review 1.  Value-based medicine and ophthalmology: an appraisal of cost-utility analyses.

Authors:  Gary C Brown; Melissa M Brown; Sanjay Sharma; Heidi Brown; Lindsay Smithen; David B Leeser; George Beauchamp
Journal:  Trans Am Ophthalmol Soc       Date:  2004

2.  Value based medicine.

Authors:  S M Kymes; K D Frick
Journal:  Br J Ophthalmol       Date:  2005-05       Impact factor: 4.638

3.  The goal of value-based medicine analyses: comparability. The case for neovascular macular degeneration.

Authors:  Gary C Brown; Melissa M Brown; Heidi C Brown; Sylvia Kindermann; Sanjay Sharma
Journal:  Trans Am Ophthalmol Soc       Date:  2007

4.  The burden of age-related macular degeneration: a value-based medicine analysis.

Authors:  Gary C Brown; Melissa M Brown; Sanjay Sharma; Joshua D Stein; Zachary Roth; Joseph Campanella; George R Beauchamp
Journal:  Trans Am Ophthalmol Soc       Date:  2005

5.  Health utilities for children and adults with type 1 diabetes.

Authors:  Joyce M Lee; Kirsten Rhee; Michael J O'grady; Anirban Basu; Aaron Winn; Priya John; David O Meltzer; Craig Kollman; Lori M Laffel; Jean M Lawrence; William V Tamborlane; Tim Wysocki; Dongyuan Xing; Elbert S Huang
Journal:  Med Care       Date:  2011-10       Impact factor: 2.983

6.  Variation in treatment preferences and care goals among older patients with diabetes and their physicians.

Authors:  Marshall H Chin; Melinda L Drum; Lei Jin; Morgan E Shook; Elbert S Huang; David O Meltzer
Journal:  Med Care       Date:  2008-03       Impact factor: 2.983

Review 7.  A review of health utilities across conditions common in paediatric and adult populations.

Authors:  Jean-Eric Tarride; Natasha Burke; Matthias Bischof; Robert B Hopkins; Linda Goeree; Kaitryn Campbell; Feng Xie; Daria O'Reilly; Ron Goeree
Journal:  Health Qual Life Outcomes       Date:  2010-01-27       Impact factor: 3.186

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.